Health and Rehabilitation Research Institute, Auckland University of Technology, Auckland, New Zealand; Waitemata Pain Service, Department of Anaesthesiology and Perioperative Medicine, North Shore Hospital, Auckland, New Zealand.
Department of Psychology, University of Zurich, Zurich, Switzerland.
J Sex Med. 2017 Nov;14(11):1357-1364. doi: 10.1016/j.jsxm.2017.09.003. Epub 2017 Sep 28.
Research has repeatedly suggested genetic and environmental factors in the etiology underlying female sexual dysfunction (FSD). Because sexual functioning is a highly variable trait, epigenetics could provide a promising approach to tackle the origins of FSD and consequently offer a step-change in our understanding of these problems.
To identify differentially methylated CpG positions for sexual functioning in a sample of monozygotic twin pairs discordant for sexual functioning.
The sample consisted of 33 trait-discordant monozygotic twin pairs (mean age = 54.1 years, SD = 9.05) from the Twins UK Registry. Phenotypic data on sexual desire, arousal, lubrication, orgasm, satisfaction, and pain were collected using the Female Sexual Function Index-Lifelong (FSFI-LL). The Illumina Infinium HumanMethylation 450 DNA BeadChip was used for epigenome-wide analyses of DNA methylation in whole-blood samples.
Comparison of DNA methylation patterns associated with the FSFI-LL total score and its six subdomains.
Two differentially methylated CpG positions (cg09580409 and cg14734994) reaching experiment-wide statistical significance were found for overall sexual functioning, mapping to MGC45800 and the threonine synthase-like 2 gene (THNSL2), respectively. Furthermore, potential biologically relevant candidates for sexual desire (CUB and zona pellucida-like domains 1, CUZD1) and satisfaction (solute carrier family 6 member 19, SLC6A19) were identified.
THNSL2 and SLC6A19, which have been linked to weight and adiposity, might represent novel candidates for sexual problems in women.
This is the first study to investigate epigenetic mechanisms underlying FSD. The study used a relative small sample of monozygotic female twins. The cutoff to determine discordance in sexual problems was chosen based on a 10% FSFI score difference. Therefore, the results have to be interpreted with caution and need replication in larger clinical samples.
Understanding how genes and environment interact to influence our sexuality might inform clinical practice and lead to new treatments for women experiencing FSD. Burri A, Leupin M, Spector T, Marinova Z. Differential DNA Methylation in Monozygotic Twins Discordant for Female Sexual Functioning. J Sex Med 2017;14:1357-1364.
研究反复表明,女性性功能障碍(FSD)的病因存在遗传和环境因素。由于性功能是一个高度可变的特征,表观遗传学可能提供一种有前途的方法来解决 FSD 的起源问题,并因此在我们对这些问题的理解上取得重大进展。
在性性功能障碍的单卵双胞胎对中识别与性功能相关的差异甲基化 CpG 位置。
该样本包括来自英国双胞胎登记处的 33 对性性功能障碍的单卵双胞胎(平均年龄为 54.1 岁,标准差为 9.05)。使用女性性功能指数终身(FSFI-LL)收集性欲、唤起、润滑、高潮、满足和疼痛的表型数据。使用 Illumina Infinium HumanMethylation 450 DNA 珠芯片对全血样本中的 DNA 甲基化进行全基因组分析。
比较与 FSFI-LL 总分及其六个亚域相关的 DNA 甲基化模式。
THNSL2 和 SLC6A19 与体重和肥胖有关,它们可能是女性性功能障碍的新候选基因。
这是第一项研究女性性功能障碍的表观遗传机制的研究。该研究使用了相对较小的单卵双胞胎女性样本。为了确定性问题的不和谐,选择了基于 10% FSFI 评分差异的截止值。因此,结果必须谨慎解释,并需要在更大的临床样本中进行复制。
理解基因和环境如何相互作用影响我们的性行为,可能为临床实践提供信息,并为女性性功能障碍患者带来新的治疗方法。